75N91023C00042
Definitive Contract
Overview
Government Description
ARPA-H SBIR PHASE II TOPIC ARPA-H 04 INTRA-OPERATIVE CONTRAST AGENTS
Awardee
Awarding / Funding Agency
Place of Performance
Portland, OR 97239 United States
Pricing
Fixed Price
Set Aside
Small Business Set Aside - Total (SBA)
Extent Competed
Full And Open Competition After Exclusion Of Sources
Analysis Notes
Amendment Since initial award the Potential Award value has increased 3% from $4,098,757 to $4,218,974.
Trace Biosciences was awarded
Definitive Contract 75N91023C00042 (75N910-23-C-00042)
for Arpa-H Sbir Phase Ii Topic Arpa-H 04 Intra-Operative Contrast Agents
worth up to $4,218,974
by the National Institutes of Health
in September 2023.
The contract
has a duration of 4 years and
was awarded
through solicitation A Solicitation of the Advanced Research Project Agency for Health (ARPA-H) for Small Business Innovative Research (SBIR) Contract Proposals- SOLICITATION AND ALL AMENDMENTS (1-4)
with a Small Business Total set aside
with
NAICS 541715 and
PSC AN13
via direct negotiation acquisition procedures with 2 bids received.
SBIR Details
Research Type
Small Business Innovation Research Program (SBIR) Phase I
Title
ARPA-H SBIR PHASE II TOPIC ARPA-H 04 INTRA-OPERATIVE CONTRAST AGENTS
Abstract
This project plans to synthesize and characterize novel nerve-specific fluorescence guided surgery (FGS) contrast agents to select a bright, water-soluble lead compound for clinical translation with optimal nerve visualization, functional assessment performance, and clinically relevant pharmacology and toxicology (pharm/tox) profiles for follow-on Investigational New Drug-enabling studies and first-in-human trials.
Research Objective
The goal of phase I is to establish the technical merit, feasibility, and commercial potential of proposed R&D efforts and determine the quality of performance of the small business awardee organization.
Topic Code
AH04
Agency Tracking Number
75N91023C00042
Solicitation Number
75N91023R00041
Contact
Connor Barth
Status
(Open)
Last Modified 7/16/25
Period of Performance
9/15/23
Start Date
9/14/27
Current End Date
9/14/27
Potential End Date
Obligations
$4.2M
Total Obligated
$4.2M
Current Award
$4.2M
Potential Award
Award Hierarchy
Definitive Contract
75N91023C00042
Subcontracts
Activity Timeline
Labor Services Billing
Annual labor billing rates and FTE reported for 75N91023C00042
| Year | Services Invoiced | Hours | FTE | Blended Rate |
|---|---|---|---|---|
| 2023 | $99,863 | 513.0 | 0.3 | $194.66 |
Opportunity Lifecycle
Procurement history for 75N91023C00042
Transaction History
Modifications to 75N91023C00042
People
Suggested agency contacts for 75N91023C00042
Competition
Number of Bidders
2
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Performance Based Acquisition
Yes
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
YGDTEJXJC9G8
Awardee CAGE
9HEB7
Agency Detail
Awarding Office
75N992 ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Funding Office
75N992
Created By
hhslharris3
Last Modified By
hhsssnyder
Approved By
hhsssnyder
Legislative
Legislative Mandates
None Applicable
Performance District
OR-01
Senators
Jeff Merkley
Ron Wyden
Ron Wyden
Representative
Suzanne Bonamici
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Advanced Research Projects Agency for Health-NIH, National Institutes of Health, Department of Health and Human Services (075-0837) | Health research and training | Other services from non-Federal sources (25.2) | $599,180 | 100% |
Modified: 7/16/25